Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US EPA to OK methyl jasmonate product

The US EPA proposes to approve US company Becker Underwood’s (now part of BASF) biochemical insecticidal seed treatment, Tariss (methyl jasmonate 0.037%), for the control of flea beetles on canola, rapeseed, mustard, safflowers, sunflowers and camelina (false flax). Methyl jasmonate is a new active ingredient that acts by inducing systemic acquired resistance. It is the principal derivative of the plant hormone, jasmonate. Methyl jasmonate is present in most fruit and is a regular part of the human diet, the EPA notes. It has negligible toxicity and presents little, if any, risk to non-target organisms. Becker Underwood filed an approval application for methyl jasmonate in December 2011, which was posted by the EPA under the Scimitar name last year ( Agrow No 643, p 20). BASF acquired Becker Underwood in November 2012 ( Agrow No 654, p 2). The proposed approval is open to public comment until March 8th.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG007259

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel